Amiklas 250mg Injection
Marketer
Metamorf Lifesciences
Salt Composition
Amikacin (250mg)
Overview Amiklas 250mg Injection
Amiklas 250mg Injection combats a broad spectrum of bacterial infections, offering preventative and therapeutic applications. Its uses encompass infections affecting the urinary system, skeletal system, lungs (such as pneumonia), central nervous system, and bloodstream, among other sites. Prophylactic use is also common in hospitalized individuals. This antibiotic functions by inhibiting bacterial proliferation. Administered intravenously (drip infusion) or via intramuscular injection by a healthcare professional, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule, maintaining consistent intervals, is crucial. Completion of the entire course is vital, even with symptom improvement, to prevent relapse or exacerbation. Typical adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or lack of clinical improvement necessitate consultation with your physician. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to your doctor's instructions is paramount, including regular monitoring of kidney function, hearing acuity, and urinalysis. This medicine is contraindicated during pregnancy. Disclose pregnancy, pregnancy planning, or breastfeeding to your doctor.
Uses of Amiklas 250mg Injection
Infections caused by bacteria
Major Benefits of Amiklas 250mg Injection:
This medication will be administered by your physician or their associate; self-medication is strongly discouraged.
Common Side effects of Amiklas 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Amiklas 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Amiklas 250mg Injection works:
Amiklas 250mg injection is a bacterial growth inhibitor; its antibiotic action arises from disruption of crucial protein synthesis pathways necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Amiklas 250mg Injection does not interact negatively with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Amiklas 250mg Injection during pregnancy poses a confirmed risk to fetal development, thus it is contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Amiklas 250mg injections pose minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, thus presenting no significant threat to the infant.
DrivingUNSAFE
Administering Amiklas 250mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from driving if these effects manifest.
KidneyCAUTION
For individuals with kidney impairment, the administration of Amiklas 250mg Injection requires careful consideration. A modified dosage of Amiklas 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Amiklas 250mg Injection appears safe for use in individuals with hepatic impairment. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Amiklas 250mg Injection :
Omit a dose of Amiklas 250mg Injection? Seek medical advice immediately.
Facts to Know About Amiklas 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Aminoglycoside antibiotics |
3,018 People bought this recently